VANCOUVER, Washington, Sept. 04, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a clinical-stage biotechnology company advancing leronlimab, a first-in-class ...
ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR) announced today that its management team’s presentation at Jefferies’ 2024 Global Healthcare Conference will now ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈